• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018 年度回顾:中轴型脊柱关节炎。

One year in review 2018: axial spondyloarthritis.

机构信息

Rheumatology Unit, Department of Clinical and experimental Medicine, University of Pisa, Italy.

Rheumazentrum Ruhrgebiet, Herne, Germany.

出版信息

Clin Exp Rheumatol. 2019 Nov-Dec;37(6):889-898. Epub 2019 Nov 28.

PMID:31796161
Abstract

Spondyloarthritis (SpA) is the umbrella term for a broad spectrum of inflammatory rheumatic diseases with typical but also rather different clinical manifestations, limited laboratory abnormalities and characteristic imaging features. For classification purposes, a so-called non-radiographic form (nr-axSpA) is differentiated from a radiographic one (r-axSpA) which is almost identical to the classical ankylosing spondylitis (AS) that is genetically strongly associated with the major histocompatibility complex class 1 antigen HLA-B27. In axSpA, the axial skeleton is affected by both inflammation and new bone formation, and joints might be affected. Rather typical musculoskeletal manifestations of SpA are enthesitis and dactylitis, the latter mainly in psoriatic arthritis (PsA). Extra-articular manifestations such as acute anterior uveitis (AAU), psoriasis (PsO) and inflammatory bowel disease (IBD) are also typical of SpA. In this paper we review the literature on axial SpA (ax-SpA) of 2018 (Medline search of articles published from 1st January 2018 to 31st January 2019).

摘要

脊柱关节炎(SpA)是一组广泛的炎症性风湿性疾病的总称,具有典型但也相当不同的临床表现、有限的实验室异常和特征性的影像学特征。为了分类目的,将一种所谓的非放射学形式(nr-axSpA)与放射学形式(r-axSpA)区分开来,后者与经典的强直性脊柱炎(AS)几乎完全相同,AS 与主要组织相容性复合体 1 抗原 HLA-B27 遗传上有很强的关联。在 axSpA 中,轴骨骼既受到炎症又受到新骨形成的影响,关节也可能受到影响。SpA 的相当典型的肌肉骨骼表现是附着点炎和指(趾)炎,后者主要见于银屑病关节炎(PsA)。关节外表现如急性前葡萄膜炎(AAU)、银屑病(PsO)和炎症性肠病(IBD)也是 SpA 的典型表现。本文回顾了 2018 年关于轴性 SpA(ax-SpA)的文献(对 2018 年 1 月 1 日至 2019 年 1 月 31 日发表的文章进行 Medline 检索)。

相似文献

1
One year in review 2018: axial spondyloarthritis.2018 年度回顾:中轴型脊柱关节炎。
Clin Exp Rheumatol. 2019 Nov-Dec;37(6):889-898. Epub 2019 Nov 28.
2
One year in review 2018: psoriatic arthritis.2018 年回顾:银屑病关节炎。
Clin Exp Rheumatol. 2019 Mar-Apr;37(2):167-178. Epub 2019 Mar 19.
3
Axial spondyloarthritis: one year in review 2023.中轴型脊柱关节炎:2023 年回顾一年。
Clin Exp Rheumatol. 2023 Nov;41(11):2142-2150. doi: 10.55563/clinexprheumatol/9fhz98. Epub 2023 Nov 14.
4
Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.强直性脊柱炎与非放射学中轴型脊柱关节炎外周及关节外疾病的患病率:一项荟萃分析。
Arthritis Res Ther. 2016 Sep 1;18(1):196. doi: 10.1186/s13075-016-1093-z.
5
Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.急性前葡萄膜炎及脊柱关节炎的其他关节外表现。
J Med Life. 2015 Jul-Sep;8(3):319-25.
6
One year in review 2021: axial spondyloarthritis.2021 年回顾:轴性脊柱关节炎。
Clin Exp Rheumatol. 2021 Nov-Dec;39(6):1272-1281. doi: 10.55563/clinexprheumatol/jlyd1l. Epub 2021 Nov 25.
7
Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?脊柱关节炎患者葡萄膜炎治疗的进展——是时候采用生物疗法了吗?
Rom J Ophthalmol. 2018 Apr-Jun;62(2):114-122.
8
Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.目前ASAS关于阳性家族史的专家定义在识别轴性脊柱关节炎方面是否有用?来自SPACE和DESIR队列的结果。
Arthritis Res Ther. 2017 May 31;19(1):118. doi: 10.1186/s13075-017-1335-8.
9
Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.脊柱关节炎相关炎症性肠病患者的关节炎、肌腱端炎和前葡萄膜炎的病例对照研究:共存银屑病的作用。
J Rheumatol. 2017 Sep;44(9):1341-1346. doi: 10.3899/jrheum.161518. Epub 2017 Apr 15.
10
Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.风湿病评估的优化——包括强直性脊柱炎在内的轴向型脊柱关节炎的实际情况。
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-96-104. Epub 2014 Oct 30.

引用本文的文献

1
Neuropathic Pain and its Relationship With Fibromyalgia, Vitamin D Status and Medication Use in Patients With Ankylosing Spondylitis.强直性脊柱炎患者的神经性疼痛及其与纤维肌痛、维生素D状态和药物使用的关系。
J Rheum Dis. 2021 Jul 1;28(3):126-132. doi: 10.4078/jrd.2021.28.3.126.
2
Clinical characteristics of ankylosing spondylitis patients depending on neuropathic pain.根据神经性疼痛分类的强直性脊柱炎患者的临床特征
Reumatologia. 2023;61(2):104-108. doi: 10.5114/reum/163223. Epub 2023 May 10.
3
Epicardial adipose tissue thickness and growth differentiation factor 15 in axial spondyloarthritis: A cross-sectional study.
腹侧脂肪组织厚度和生长分化因子 15 在轴性脊柱关节炎中的相关性:一项横断面研究。
Saudi Med J. 2022 Sep;43(9):1020-1026. doi: 10.15537/smj.2022.43.9.20220304.
4
Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial.司库奇尤单抗治疗中轴型脊柱关节炎患者脊柱疼痛迅速改善:一项随机对照IIIb期试验的主要结果
Ther Adv Musculoskelet Dis. 2021 Oct 22;13:1759720X211051471. doi: 10.1177/1759720X211051471. eCollection 2021.
5
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.Filgotinib 可减少强直性脊柱炎的椎体和脊柱旁后炎症:来自 TORTUGA 试验的结果。
Rheumatology (Oxford). 2022 May 30;61(6):2388-2397. doi: 10.1093/rheumatology/keab758.
6
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).在活动性强直性脊柱炎患者中,12 周时 fingolimod 对骶髂关节磁共振成像结构病变的影响( TORTUGA 试验)。
Rheumatology (Oxford). 2022 May 5;61(5):2063-2071. doi: 10.1093/rheumatology/keab543.
7
Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.炎症性风湿病中葡萄膜炎的免疫病理生理学和临床影响:最新进展。
Eur J Clin Invest. 2021 Aug;51(8):e13572. doi: 10.1111/eci.13572. Epub 2021 May 5.